Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.6% beneficial ownership stake in Trade Desk, Inc.'s Class A Stock.
NYSE
BlackRock, Inc. reported an amended beneficial ownership of 6.5% in Titan Machinery Inc. common stock, totaling 1,524,675 shares.
NYSE
BlackRock, Inc. has reported a 5.5% beneficial ownership stake in Tourmaline Bio, Inc., holding 1,411,832 shares of common stock as of September 30, 2025.
NYSE
BlackRock, Inc. reported an 8.4% beneficial ownership in Universal Display Corp's common stock as of September 30, 2025.
NYSE
BlackRock, Inc. has increased its beneficial ownership in Wendy's Co to 12.1% of common stock, holding over 23 million shares.
NYSE
BlackRock, Inc. has reported a 5.1% beneficial ownership stake in MODIV INDUSTRIAL INC's Class C Stock as of September 30, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, disclosing a 7.7% beneficial ownership stake in Orchid Island Capital, Inc. as of September 30, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.5% beneficial ownership stake in EyePoint Pharmaceuticals, Inc. common stock as of September 30, 2025.
NYSE
BlackRock, Inc. has reported an increased beneficial ownership of 14.3% in Frontdoor Inc.'s common stock, totaling 10,408,652 shares.
NYSE
BlackRock, Inc. has reported a 5.7% beneficial ownership stake in Guardian Pharmacy Services, Inc.'s Class A Stock as of September 30, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.9% beneficial ownership stake in Hallador Energy Co. common stock.
NYSE
BlackRock, Inc. filed an Amendment No. 18 to its Schedule 13G, disclosing a 9.1% beneficial ownership in Host Hotels and Resorts Inc., representing 62,535,475 shares as of September 30, 2025.
NYSE
SCHEDULE: BlackRock Boosts Incyte Stake to 7.8%
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.8% beneficial ownership stake in Incyte Corporation as of September 30, 2025.
NYSE
BlackRock, Inc. has reported a reduced beneficial ownership in Inhibrx Biosciences, Inc. to 4.7% of common stock.
NYSE
BlackRock, Inc. has reported an increased beneficial ownership of 6.2% in Interactive Brokers Group Inc.'s Class A Stock, holding 27,619,620 shares.
NYSE
BlackRock, Inc. has reported an 8.5% beneficial ownership stake in the iShares MSCI India ETF, holding 14,867,393 shares as of September 30, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.6% in the iShares Nasdaq Top 30 Stocks ETF as of September 30, 2025.
NYSE
BlackRock, Inc. has reported a 5.1% beneficial ownership stake in Dakota Gold Corp., holding 5,708,431 shares of common stock.
NYSE
BlackRock, Inc. has increased its beneficial ownership in Kearny Financial Corp's common stock to 6.5%, holding over 4.2 million shares.
NYSE
BlackRock, Inc. has reported an increased beneficial ownership of 12.7% in Kratos Defense & Security Solutions, Inc., holding 21,491,945 common shares.
NYSE
BlackRock, Inc. has reported a passive beneficial ownership of 5.2% of LENSAR, Inc.'s common stock as of September 30, 2025.
NYSE
BlackRock, Inc. has reported a 5.1% beneficial ownership stake in LENZ THERAPEUTICS, INC. as of September 30, 2025, through a Schedule 13G filing.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.0% beneficial ownership stake in Lexeo Therapeutics, Inc.'s Common Stock.
NYSE
BlackRock, Inc. has reported a 5.8% beneficial ownership stake in LifeVantage Corp, holding 732,063 shares of common stock.
NYSE
BlackRock, Inc. has reported beneficial ownership of 5.5% of LOANDEPOT INC CLASS A Common Stock as of September 30, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 16 to Schedule 13G, reporting a beneficial ownership of 15.4% of MGE Energy Inc.'s Common Stock as of September 30, 2025.
NYSE
BlackRock, Inc. has disclosed a 9.1% beneficial ownership stake in MACOM Technology Solutions Holdings Inc., holding 6,742,929 shares of common stock.
NYSE
BlackRock, Inc. has reported a 4.7% beneficial ownership stake in Mamas Creations Inc., holding 1,920,649 common shares as of September 30, 2025.
NYSE
BlackRock, Inc. has disclosed an increased passive ownership stake of 5.9% in Maravai LifeSciences Holdings, Inc., holding over 8.5 million shares.
NYSE
BlackRock, Inc. reports a 4.2% passive ownership stake in MarketAxess Holdings Inc., holding 1,572,513 common shares.